Bay Street News, October 5th, 2020

Real-World Population Representative of Patients Enrolled in GALACTIC-HF Indicate a High-Need, High-Risk Population with Heart FailureNew Results from COSMIC-HF Show Treatment […]

CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]

DALLAS, Oct. 05, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the […]

NEWMARKET, Ontario, Oct. 05, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced […]

Records Highest Quarterly Revenue Growth Rate Since the Company’s 2011 IPO, Highest Quarterly Revenue Since FY2013Society6 Group Posts Record Quarterly […]

WASHINGTON, Oct. 05, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that four professionals have been named […]

Angel’s pipeline will feature Corvus’ three clinical-stage candidates – ciforadenant, CPI-006 and CPI-818 – and its preclinical BTK inhibitor programStrategic […]

Enrollment in first three cohorts complete; final cohort now enrolling with plans to initiate a pivotal study before year-endData continues […]

RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company […]

BridgeBio to Acquire All Outstanding Shares of Eidos it Does Not Already OwnAgreement Brings BridgeBio’s Clinical Development and Commercial Development […]